Bcal Diagnostics Limited has released a press release.
Appendix 4E and Annual Report to shareholders
Earlier from Bcal Diagnostics
- BCAL Takes Interest in Genetic Signatures to 18.46%
- BCAL Secures Funding for FY2027 Update
- BCAL to Acquire Shares in Genetic Signatures
- BCAL Secures Funding for FY2027